Skip to main content
. 2021 May 1;17(4):267–270. doi: 10.1002/cld.1041

FIG 2.

FIG 2

Current and future treatments. Current FDA‐approved treatments are chelating agents and zinc salts. Whereas zinc salts work at preventing copper absorption in the intestine, chelating agents bind copper in the bloodstream. Maintenance treatments include bis‐choline TTM, which works in multiple locations, including hepatocytes, brain, and the bloodstream. 16